At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TMDX TransMedics Group, Inc.
Pre-Market Trading 05-06 05:38:03 EDT
127.99
+3.55
+2.85%
盘前128.20
+0.21+0.16%
05:17 EDT
High129.66
Low123.65
Vol1.54M
Open125.00
D1 Closing124.44
Amplitude4.83%
Mkt Cap4.22B
Tradable Cap4.07B
Total Shares32.94M
T/O196.19M
T/O Rate4.85%
Tradable Shares31.81M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.